Form 4 for BLTE BELITE BIO, INC
Accepted 2026-05-07 16:15:04 ET · period of report 2026-05-06 · accession 0001193125-26-211974 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-05-07 16:15 | 2026-05-06 | BLTE | MATA NATHAN L. | CSO | S - Sale | $153.84 | -1,000 | 666 | -60% | -$153.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American depositary share | 2026-05-06 | S | D | 8 | $151.57 | 1,658 | D | — | — | (F1) Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. (F3) Represents the weighted average price of shares sold at prices that ranged from $151.17 to $151.97. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
| 2 | Common | American depositary share | 2026-05-06 | S | D | 424 | $152.67 | 1,234 | D | — | — | (F1) Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. (F4) Represents the weighted average price of shares sold at prices that ranged from $152.25 to $152.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
| 3 | Common | American depositary share | 2026-05-06 | S | D | 128 | $153.42 | 1,106 | D | — | — | (F1) Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. (F5) Represents the weighted average price of shares sold at prices that ranged from $153 to $153.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
| 4 | Common | American depositary share | 2026-05-06 | S | D | 240 | $154.41 | 866 | D | — | — | (F1) Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. (F6) Represents the weighted average price of shares sold at prices that ranged from $154.02 to $154.64. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
| 5 | Common | American depositary share | 2026-05-06 | S | D | 100 | $155.97 | 766 | D | — | — | (F1) Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. |
| 6 | Common | American depositary share | 2026-05-06 | S | D | 100 | $156.00 | 666 | D | — | — | (F1) Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. |